Patent directory · USPTO A61K / A61P
Patents matching “Prime Bio, Inc.”
6 pharma patents match "Prime Bio, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 6 pharmaceutical patents matching "Prime Bio, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12233119
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
granted -
US 12194090
Tetanus vaccine platform for embedding COVID-19 vaccine
granted -
US 11957740
Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potency
granted -
US 11771752
Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins
granted -
US 11389497
Pharmaceutical composition for treating cancer
granted -
US 11040090
Botulinum neurotoxin compositions
granted